BRONCHO- AND ANGIOPLASTY LOBECTOMY AS AN ALTERNATIVE TO PNEUMONECTOMY IN TREATMENT OF NON-SMALL-CELL LUNG CANCER
https://doi.org/10.24884/0042-4625-2018-177-3-19-24
Abstract
The objective of the study is to substantiate the applying of broncho- and angioplasty lobectomy as an alternative to pneumonectomy in NSCLC.
Material and methods. The results of treatment of two comparable groups of patients with NSCLC were presented. In one group, patients underwent broncho- or angioplasty lobectomies (group A), in another – pneumonectomy (group B). The number of complications, overall and disease-free survival in both groups, as well as the factors affected the results were analyzed.
Results. The number of postoperative complications in group A and group B was 12.5 % and 15.6 %, respectively. The median of disease-free survival and overall survival in both groups did not differ meaningfully, consisting of 20 months and 48 months in group A, and 19 months and 25 months in group B (p=0.91) and (p=0.97). The results of treatment were meaningfully affected only by the stage of the disease (p=0.017) and multidisciplinary treatment (p=0.007), including chemotherapy and radiation therapy.
Conclusions. Performing of broncho- and angioplasty lobectomies can be justified as an alternative to lung removal in NSCLC within the multidisciplinary treatment.
About the Authors
A. V. Reshetov
Federal State Budgetary Educational Institution of Higher Education North-Western State Medical University named after I. I. Mechnikov
Russian Federation
Russian Federation
St. Petersburg
A. V. Elkin
Federal State Budgetary Educational Institution of Higher Education North-Western State Medical University named after I. I. Mechnikov
Russian Federation
Russian Federation
St. Petersburg
G. V. Nikolaev
Federal State Budgetary Institution «Almazov National Medical Research Centre» of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
St. Petersburg
S. S. Stepanov
Federal State Budgetary Institution «Almazov National Medical Research Centre» of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
St. Petersburg
References
1. Deslauriers J., Gregoire J., Jacques L. et al. Sleeve lobectomy versus pneumonectomy for lung cancer : a comparative analysis of survival and sites or recurrences // Ann. Thorac. Surg. 2004. Vol. 77, № 6. Р. 1152–1156.
2. Melloul E., Tgger B., Krueger T. et al. Mortality, complications and loss of pulmonary function after pneumonectomy vs, sleeve lobectomy in patients younger and older than 70 years // Interact. Cardiovasc. Thorac. Surg. 2008. Vol. 7, № 6. P. 986–989.
3. Yildizeli B., Fadel E., Mussot S. et al. Morbidity, vortality, and long-term survival after sleeve lobectomy for non-small cell lung cancer // Eur. J. Cardiotorac. Surg. 2007. Vol. 31, № 1. P. 95–102.
4. Does sleeve lobectomy concomitant with or without pulmonary reconstruction (double sleeve) have favorable results for non-small cell lung cancer compared with pneumonectomy? A meta-analysis / Z. Ma, A. Dong, J. Fan, H. Cheng // Eur. J. Cardiothorac. Surg. 2007. Vol. 32. № 1. P. 20–28.
5. Takeda S., Maeda H., Koma M. et al. Comparison of surgical results after pneumonectomy and sleeve lobectomy for non-small cell lung cancer : trends over time and 20-year institutional experience // Eur. J. Cardiothorac. Surg. 2006. Vol. 29, № 3. P. 276–280.
6. Levchenko E. V., Levchenko N. E., Jurin R. I. i dr. Otdalennie rezultati bronhoplasticheskih vmeshatelstv po sravneniu s pnevmonectomiei pri rake legkogo // Voprosy oncologii. 2017. № 2. Р. 234–240.
7. Nagayasu T., Yamasaki N., Tsuchiya T. et al. The evolution of bronchoplasty and broncho-angioplasty as treatment for lung cancer : evaluation of 30 years of data from a single institution // Eur. J. Cardiothorac. Surg. 2016. Vol. 49, № 1. P. 300–306.
8. Tagawa T., Iwata T., Nakajima T. et al. Evolution of a Lung-Sparing Strategy with Sleeve Lobectomy and Induction Therapy for Non-small Cell Lung Cancer : 20-Year Experience at a Single Institution // World J. Surg. 2016. Vol. 40, № 4. P. 906–912.
9. Martin-Ucar A. E., Chaudhuri N., Edwards J. G. et al. Can pneumonectomy for non-small cell lung cancer be avoided? An audit of parenchymal sparing lung surgery // Eur. J. Cardiothorac. Surg. 2002. Vol. 21. P. 601–605.
10. Pan X., Tantai J., Lin L. et al. Comparison of short and long-term results between sleeve resection and pneumonectomy in lung cancer patients over 70 years old : 10 years experience from a single institution in China // Thorac. Cancer. 2014. Vol. 5, № 6. P. 494–499.
11. The role of sleeve resection in advanced nodal disease / J. Schirren, M. Eberlein, A. Fischer, S. Bolukbas // Eur. J. Cardiothorac. Surg. 2011. Vol. 40, № 5. P. 1157–1163.
12. Ludwig C., Stoelben E., Olschewski M. et al. Comparision of morbidity, 30-day mortality, and longest survival after pneumonectomy and sleeve lobectomy for non-small cell lung carcinoma // Аnn. Thorac. Surg. 2005. Vol. 79, P. 968–973.
13. Local control of disease related to lymph node involvement in non-small cell lung cancer after sleeve lobectomy compare with pneumonectimy / Y. T. Kim, C. H. Kang, S. W. Sung, J. H. Kim // Ann. Thorac. Surg. 2005. Vol. 79, № 4. P. 1153–1161.
14. Decaluwe H., De Leven P., Vansteenkiste J. et al. Surgical multimodality treatment for baseline resectable stege III A-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival // Eur. J. Cardiothorac. Surg. 2009. Vol. 36, № 3. P. 433–439.
15. Weder W., Collaud S., Eberhardt W. E. et al. Pneumonectomy is a va luable treatment option after neoadjuvant therapy for stage III nonsmall-cell lung cancer // J. Thorac. Cardiovasc. Surg. 2010. Vol. 139, № 6. P. 1424–1430.
16. Hillinger S., Weder W. Extended surgical resection in stage III non-small cell lung cancer // Front Radiat. Ther. Oncol. 2010. Vol. 42. P. 115–121.
17. NSCLC Meta-analyses Collaborative Group. Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer : two meta-analyses of individual patient data // The Lancet. 2010. Vol. 375, № 9722. P. 1267–1277.
Review
For citations:
Reshetov A.V., Elkin A.V., Nikolaev G.V., Stepanov S.S. BRONCHO- AND ANGIOPLASTY LOBECTOMY AS AN ALTERNATIVE TO PNEUMONECTOMY IN TREATMENT OF NON-SMALL-CELL LUNG CANCER. Grekov's Bulletin of Surgery. 2018;177(3):19-24. (In Russ.) https://doi.org/10.24884/0042-4625-2018-177-3-19-24
Views:
640
Email this article 